Adage Capital Partners’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $62.1M | Sell |
|
|||||
|
2023
Q3 | $61.5M | Sell |
|
|||||
|
2023
Q2 | $48.2M | Buy |
|
|||||
|
2023
Q1 | $38.4M | Buy |
|
|||||
|
2022
Q4 | $3.13M | Hold |
|
|||||
|
2022
Q3 | $1.75M | Hold |
|
|||||
|
2022
Q2 | $1.48M | Sell |
|
|||||
|
2022
Q1 | $4.67M | Buy |
|
|||||
|
2021
Q4 | $4.9M | Hold |
|
|||||
|
2021
Q3 | $5.29M | Hold |
|
|||||
|
2021
Q2 | $6.32M | Hold |
|
|||||
|
2021
Q1 | $6.58M | Hold |
|
|||||
|
2020
Q4 | $8.32M | Hold |
|
|||||
|
2020
Q3 | $10.5M | Sell |
|
|||||
|
2020
Q2 | $8.72M | Buy |
|
|||||
|
2020
Q1 | $2.22M | Hold |
|
|||||
|
2019
Q4 | $2.94M | Hold |
|
|||||
|
2019
Q3 | $7.68M | Hold |
|
|||||
|
2019
Q2 | $10.7M | Sell |
|
|||||
|
2019
Q1 | $32.2M | Buy |
|
|||||
|
2018
Q4 | $17M | Buy |
|
|||||
|
2018
Q3 | $21.9M | Sell |
|
|||||
|
2018
Q2 | $33.2M | Sell |
|
|||||
|
2018
Q1 | $45.1M | Buy |
|
|||||
|
2017
Q4 | $30.2M | Buy |
|
|||||
|
2017
Q3 | $24.8M | Buy |
|
|||||
|
2017
Q2 | $10.6M | Hold |
|
|||||
|
2017
Q1 | $7.91M | Buy |
|
|||||
|
2016
Q4 | $1.21M | Hold |
|
|||||
|
2016
Q3 | $1.36M | Sell |
|
|||||
|
2016
Q2 | $1.6M | Sell |
|
|||||
|
2016
Q1 | $2.29M | Hold |
|
|||||
|
2015
Q4 | $2.87M | Hold |
|
|||||
|
2015
Q3 | $3.3M | Buy |
|
|||||
|
2015
Q2 | $2.69M | Hold |
|
|||||
|
2015
Q1 | $6.92M | Buy |
|
|||||
|
2014
Q4 | $3.51M | Buy |
|